37 results on '"Yavuz, Furkan"'
Search Results
2. Responses to Hypoxia: How Fructose Metabolism and Hypoxia-Inducible Factor-1a Pathways Converge in Health and Disease
- Author
-
Kanbay, Mehmet, Altıntas, Alara, Yavuz, Furkan, Copur, Sidar, Sanchez-Lozada, Laura G., Lanaspa, Miguel A., and Johnson, Richard J.
- Published
- 2023
- Full Text
- View/download PDF
3. Tirzepatide and potential use for metabolically healthy obesity
- Author
-
Copur, Sidar, Tanriover, Cem, Yavuz, Furkan, Tuttle, Katherine R., and Kanbay, Mehmet
- Published
- 2023
- Full Text
- View/download PDF
4. The role of body mass index on IgA nephropathy prognosis: a systematic review and meta-analysis
- Author
-
Kanbay, Mehmet, Yildiz, Abdullah B., Yavuz, Furkan, Covic, Adrian, Ortiz, Alberto, and Siriopol, Dimitrie
- Published
- 2022
- Full Text
- View/download PDF
5. Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM)
- Author
-
Sari-Ak, Duygu, Torres-Gomez, Alvaro, Yazicioglu, Yavuz-Furkan, Christofides, Anthos, Patsoukis, Nikolaos, Lafuente, Esther M., and Boussiotis, Vassiliki A.
- Published
- 2022
- Full Text
- View/download PDF
6. The Use of Treatment Response Assessment Maps in Discriminating Between Radiation Effect and Persistent Tumoral Lesion in Metastatic Brain Tumors Treated with Gamma Knife Radiosurgery
- Author
-
Peker, Selcuk, Samanci, Yavuz, Aygun, Murat Serhat, Yavuz, Furkan, Erden, Mert Emre, Nokay, Aziz Emre, Atasoy, Ali İhsan, and Bolukbasi, Yasemin
- Published
- 2021
- Full Text
- View/download PDF
7. Evaluation of pharmaceutical companies' websites in technology development zones: the case of Türkiye.
- Author
-
YUMRUKAYA, Leyla, YAVUZ, Furkan, SÖZEN-ŞAHNE, Bilge, and YEĞENOĞLU, Selen
- Subjects
- *
CORPORATE websites , *WEB development , *CORPORATE image , *BRAND image , *PHARMACEUTICAL technology - Abstract
Technology development zones are crucial for innovation-driven sectors such as the pharmaceutical industry. In addition to their innovative characteristics, companies in technology development zones have corporate identities. In this context, websites are critical tools for building relationships with the public and stakeholders and represent their corporate identities. Thus, in this study, we examined the content of pharmaceutical companies' websites in technology development zones in Türkiye. After refining the list of pharmaceutical companies in technology development zones, their websites were evaluated according to criteria based on the literature considering their corporate characteristics. Next to the literature, their region, being global/local, having products, and collaborations are considered for comparison. There were 30 pharmaceutical companies in the 81 technology development zones. The highest and lowest scores are 34 and 5, respectively. We found no statistical significance in the scores of the companies' websites considering being global/local and collaborating. On the contrary, we found a statistical difference between groups considering the products and corporate communication scores of companies that have available products. In the pharmaceutical industry, as an innovation-driven sector, it is important to take place in competitive markets not only with innovation but also with technology-based products. Here, websites can serve as a channel for communication and strengthen their brand image. In addition, to enhance the accessibility and trustworthiness of content, websites should be built in a standardized and comprehensive manner. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. The effects of the combination of temozolomide and Eribulin on T98G human glioblastoma cell line: an ultrastructural study.
- Author
-
Tanriverdi, Gamze, Kaleci, Belisa, Yavuz, Furkan, Sahin, Hakan, Purelku, Merjem, Yazici, Zeliha, and Kokturk, Sibel
- Subjects
AUTOPHAGY ,CELL morphology ,BRAIN tumors ,TRANSMISSION electron microscopy ,CELL cycle - Abstract
Glioblastoma tumors are the most aggressive primary brain tumors that develop resistance to temozolomide (TMZ). Eribulin (ERB) exhibits a unique mechanism of action by inhibiting microtubule dynamics during the G2/M cell cycle phase. We utilized the T98G human glioma cell line to investigate the effects of ERB and TMZ, both individually and in combination. The experimental groups were established as follows: control, E5 (5 nM ERB), T0.75 (0.75 mM TMZ), T1 (1.0 mM TMZ), and combination groups (E5+T0.75 and E5+T1). All groups showed a significant decrease in cell proliferation. Apoptotic markers revealed a time-dependent increase in annexin-V expression, across all treatment groups at the 48-hour time point. Caspase-3, exhibited an increase in the combination treatment groups at the 48-hour mark. Transmission electron microscopy (TEM) revealed normal ultrastructural features in the glioma cells of the control group. However, treatments induced ultrastructural changes within the spheroid glioblastoma model, particularly in the combination groups. These changes included a dose-dependent increase in autophagic vacuoles and apoptotic morphology of the cells. In conclusion, the similarity in the mechanism of action between ERB and TMZ suggests the potential for synergistic effects when combined. Our results highlight that this combination induced severe damage and autophagy in glioma spheroids after 48 hours. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Shared decision making in patients with kidney failure
- Author
-
Kanbay, Mehmet, Basile, Carlo, Battaglia, Yuri; https://orcid.org/0000-0003-3947-1814, Mantovani, Alessandro, Yavuz, Furkan, Pizzarelli, Francesco; https://orcid.org/0000-0003-0095-953X, Luyckx, Valerie A; https://orcid.org/0000-0001-7066-8135, Covic, Adrian, Liakopoulos, Vassilios; https://orcid.org/0000-0002-7564-2724, Mitra, Sandip, Kanbay, Mehmet, Basile, Carlo, Battaglia, Yuri; https://orcid.org/0000-0003-3947-1814, Mantovani, Alessandro, Yavuz, Furkan, Pizzarelli, Francesco; https://orcid.org/0000-0003-0095-953X, Luyckx, Valerie A; https://orcid.org/0000-0001-7066-8135, Covic, Adrian, Liakopoulos, Vassilios; https://orcid.org/0000-0002-7564-2724, and Mitra, Sandip
- Abstract
'Elderly' is most commonly defined as an individual aged 65 years or older. However, this definition fails to account for the differences in genetics, lifestyle and overall health that contribute to significant heterogeneity among the elderly beyond chronological age. As the world population continues to age, the prevalence of chronic diseases, including chronic kidney disease (CKD), is increasing and CKD frequently progresses to kidney failure. Moreover, frailty represents a multidimensional clinical entity highly prevalent in this population, which needs to be adequately assessed to inform and support medical decisions. Selecting the optimal treatment pathway for the elderly and frail kidney failure population, be it hemodialysis, peritoneal dialysis, or conservative kidney management is complex, because of the presence of comorbidities associated with low survival rates and impaired quality of life. Management of these patients should involve a multidisciplinary approach including doctors from various specialties, nurses, psychologists, dieticians, and physiotherapists. Studies are mostly retrospective and observational, lacking adjustment for confounders or address selection and indication biases, making it difficult to use these data to guide treatment decisions. Throughout this review we discuss the difficulty of making a one-size-fits-all recommendation for the clinical needs of older patients with kidney failure. We advocate that a research agenda for optimization of the critical issues we present in this review be implemented. We recommend prospective studies that address these issues, and systematic reviews incorporating the complementary evidence of both observational and interventional studies. Furthermore, we strongly support a shared decision making process matching evidence with patient preferences to ensure that individualized choices are made regarding dialysis vs. conservative kidney management, dialysis modality, and optimal vascular access.
- Published
- 2024
10. Angiopoietin as a Novel Prognostic Marker in Kidney Disease
- Author
-
Yildiz, Abdullah B., primary, Copur, Sidar, additional, Tanriover, Cem, additional, Yavuz, Furkan, additional, Vehbi, Sezan, additional, Gaipov, Abduzhappar, additional, Magagnoli, Lorenza, additional, Ciceri, Paola, additional, Cozzolino, Mario, additional, and Kanbay, Mehmet, additional
- Published
- 2024
- Full Text
- View/download PDF
11. A potential approach toward the management of sepsis: The extracorporeal cytokine hemadsorption therapy
- Author
-
Yildiz, Abdullah Burak, primary, Copur, Sidar, additional, Tanriover, Cem, additional, Yavuz, Furkan, additional, Vehbi, Sezan, additional, Hasbal, Nuri Baris, additional, and Kanbay, Mehmet, additional
- Published
- 2023
- Full Text
- View/download PDF
12. İYİMSERLİK, STRES İÇEREN DURUMLAR VE BAŞA ÇIKMA: BİR DERLEME ÇALIŞMASI
- Author
-
SOLAK, Mehmet Yavuz Furkan, primary and ANLI, Gazanfer, additional
- Published
- 2023
- Full Text
- View/download PDF
13. ARE ONLINE STREAMING VIDEOS ON TRACHEOSTOMY CARE APPROPRIATE FOR MEDICAL EDUCATION?
- Author
-
Tanyıldız, Murat, primary, Yavuz, Furkan, additional, Oğuz, Sinem, additional, Yakıcı, Aslı, additional, Özden, Ömer, additional, and Gökler, Ozan, additional
- Published
- 2023
- Full Text
- View/download PDF
14. Evaluation of Ventilator-associated Pneumonia Approaches in Pediatric Intensive Care Units in Türkiye
- Author
-
Tanyıldız, Murat, primary, Yavuz, Furkan, additional, Şenköylü, Karya, additional, Özden, Ömer, additional, and Yıldızdaş, Dinçer, additional
- Published
- 2023
- Full Text
- View/download PDF
15. Shared decision making in elderly patients with kidney failure
- Author
-
Kanbay, Mehmet, primary, Basile, Carlo, additional, Battaglia, Yuri, additional, Mantovani, Alessandro, additional, Yavuz, Furkan, additional, Pizzarelli, Francesco, additional, Luyckx, Valerie A, additional, Covic, Adrian, additional, Liakopoulos, Vassilios, additional, and Mitra, Sandip, additional
- Published
- 2023
- Full Text
- View/download PDF
16. Shared decision making in elderly patients with kidney failure.
- Author
-
Kanbay, Mehmet, Basile, Carlo, Battaglia, Yuri, Mantovani, Alessandro, Yavuz, Furkan, Pizzarelli, Francesco, Luyckx, Valerie A, Covic, Adrian, Liakopoulos, Vassilios, and Mitra, Sandip
- Subjects
KIDNEY failure ,PATIENT decision making ,FRAIL elderly ,CHRONIC kidney failure ,PERITONEAL dialysis ,HOME hemodialysis - Abstract
'Elderly' is most commonly defined as an individual aged 65 years or older. However, this definition fails to account for the differences in genetics, lifestyle and overall health that contribute to significant heterogeneity among the elderly beyond chronological age. As the world population continues to age, the prevalence of chronic diseases, including chronic kidney disease (CKD), is increasing and CKD frequently progresses to kidney failure. Moreover, frailty represents a multidimensional clinical entity highly prevalent in this population, which needs to be adequately assessed to inform and support medical decisions. Selecting the optimal treatment pathway for the elderly and frail kidney failure population, be it haemodialysis, peritoneal dialysis or conservative kidney management, is complex because of the presence of comorbidities associated with low survival rates and impaired quality of life. Management of these patients should involve a multidisciplinary approach including doctors from various specialties, nurses, psychologists, dieticians and physiotherapists. Studies are mostly retrospective and observational, lacking adjustment for confounders or addressing selection and indication biases, making it difficult to use these data to guide treatment decisions. Throughout this review we discuss the difficulty of making a one-size-fits-all recommendation for the clinical needs of older patients with kidney failure. We advocate that a research agenda for optimization of the critical issues we present in this review be implemented. We recommend prospective studies that address these issues, and systematic reviews incorporating the complementary evidence of both observational and interventional studies. Furthermore, we strongly support a shared decision-making process matching evidence with patient preferences to ensure that individualized choices are made regarding dialysis vs conservative kidney management, dialysis modality and optimal vascular access. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. A potential approach toward the management of sepsis: The extracorporeal cytokine hemadsorption therapy.
- Author
-
Yildiz, Abdullah Burak, Copur, Sidar, Tanriover, Cem, Yavuz, Furkan, Vehbi, Sezan, Hasbal, Nuri Baris, and Kanbay, Mehmet
- Subjects
SYSTEMIC inflammatory response syndrome ,INTENSIVE care patients ,SEPTIC shock ,SEPSIS ,COVID-19 pandemic ,NEONATAL sepsis - Abstract
Infectious diseases are among the most common cause of morbidity and mortality among hospitalized patients while systemic inflammatory response syndrome is primarily attributed to the imbalance between pro‐inflammatory and anti‐inflammatory cytokines. Despite the improvements in the antibiotherapy alternatives and diagnostic modalities, the morbidity and mortality rates of sepsis and septic shock are relatively high among patients admitted to the intensive care units. Extracorporeal cytokine hemadsorption therapies are therapeutic approaches for such patient group with promising early results that especially have grown during COVID‐19 pandemic. In this narrative review, our aim is to evaluate the current pre‐clinical and clinical knowledge regarding the use of cytokine filtration systems among patients with septic shock. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Novel strategies in nephrology: what to expect from the future?
- Author
-
Copur, Sidar, Tanriover, Cem, Yavuz, Furkan, Soler, Maria, Ortiz, Alberto, Covic, Adrian, Kanbay, Mehmet, Universitat Autònoma de Barcelona, Institut Català de la Salut, [Copur S, Tanriover C, Yavuz F] Department of Medicine, Koc University School of Medicine, Istanbul, Turkey. [Soler MJ] Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Grup de Recerca de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Ortiz A] Department of Medicine, Universidad Autonoma de Madrid and IIS-Fundacion Jimenez Diaz, Madrid, Spain. [Covic A] Nephrology Clinic, Dialysis and Renal Transplant Center, ‘C.I. PARHON’ University Hospital, and ‘Grigore T. Popa’ University of Medicine, Iasi, Romania. [Kanbay M] Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
terapéutica::tratamiento de reemplazo renal [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Induced pluripotent stem cells ,Transplantation ,Nephrology ,Artificial kidney ,Chronic kidney disease ,Ronyons - Trasplantació ,enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::insuficiencia renal::insuficiencia renal crónica [ENFERMEDADES] ,Bioengineering ,Xenotransplantation ,Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic [DISEASES] ,Therapeutics::Renal Replacement Therapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,Insuficiència renal crònica - Tractament - Abstract
Artificial kidney; Chronic kidney disease; Xenotransplantation Ronyó artificial; Malaltia renal crònica; Xenotrasplantament Riñón artificial; Enfermedad renal crónica; Xenotrasplante Chronic kidney disease (CKD) will become the fifth global case of death by 2040. Its largest impact is on premature mortality but the number of persons with kidney failure requiring renal replacement therapy (RRT) is also increasing dramatically. Current RRT is suboptimal due to the shortage of kidney donors and dismal outcomes associated with both hemodialysis and peritoneal dialysis. Kidney care needs a revolution. In this review, we provide an update on emerging knowledge and technologies that will allow an earlier diagnosis of CKD, addressing the current so-called blind spot (e.g. imaging and biomarkers), and improve renal replacement therapies (wearable artificial kidneys, xenotransplantation, stem cell-derived therapies, bioengineered and bio-artificial kidneys). Research by A.O. is supported by IS/Fondos FEDER (PI18/01 366, PI19/00 588, PI19/00 815, DTS18/00 032, ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00 064) and PERSTIGAN AC18/00 071, ISCIII-RETIC REDinREN RD016/0009), Sociedad Española de Nefrología, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM, Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001) and SPACKDc PMP21/00 109, FEDER funds. RD16/0009.
- Published
- 2023
19. The pathophysiology and management of vascular calcification in chronic kidney disease patients
- Author
-
Kanbay, Mehmet, primary, Copur, Sidar, additional, Tanriover, Cem, additional, Yavuz, Furkan, additional, Galassi, Andrea, additional, Ciceri, Paola, additional, and Cozzolino, Mario, additional
- Published
- 2023
- Full Text
- View/download PDF
20. Thyroid hormone Beta receptor agonists for treatment of kidney disease: A promising agent?
- Author
-
Copur, Sidar, primary, Yavuz, Furkan, additional, and Kanbay, Mehmet, additional
- Published
- 2023
- Full Text
- View/download PDF
21. ARE ONLINE STREAMING VIDEOS ON TRACHEOSTOMY CARE APPROPRIATE FOR MEDICAL EDUCATION?
- Author
-
TANYILDIZ, Murat, YAVUZ, Furkan, OĞUZ, Sinem, YAKICI, Aslı Ece, ÖZDEN, Ömer, and GÖKLER, Ozan
- Subjects
HISTORY ,TRACHEOTOMY ,CROSS-sectional method ,PATIENT education ,MEDICAL education ,INTERNET ,TEACHING ,QUANTITATIVE research ,MANN Whitney U Test ,TRACHEOTOMY equipment ,MEDICAL students ,PRE-tests & post-tests ,RESEARCH ,MOTION pictures ,DATA analysis software ,CRITICAL care nurses - Abstract
Copyright of Journal of Advanced Research in Health Sciences (JARHS) / Sağlık Bilimlerinde İleri Araştırmalar Dergisi (SABİAD) is the property of Journal of Advanced Research in Health Sciences (JARHS) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
22. Novel strategies in nephrology: what to expect from the future?
- Author
-
Copur, Sidar, primary, Tanriover, Cem, additional, Yavuz, Furkan, additional, Soler, Maria J, additional, Ortiz, Alberto, additional, Covic, Adrian, additional, and Kanbay, Mehmet, additional
- Published
- 2022
- Full Text
- View/download PDF
23. A state of art management of a bilateral basal ganglia germinoma: case report
- Author
-
Yavuz, Furkan, primary, Samanci, Yavuz, additional, Kulac, Ibrahim, additional, and Peker, Selcuk, additional
- Published
- 2022
- Full Text
- View/download PDF
24. Novel strategies in nephrology: what to expect from the future?
- Author
-
Çöpür, Sidar (ORCID 0000-0003-0190-2746 & YÖK ID 368625); Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580); Tanrıöver, Cem; Yavuz, Furkan, Soler, Maria J.; Ortiz, Alberto; Covic, Adrian, School of Medicine, Çöpür, Sidar (ORCID 0000-0003-0190-2746 & YÖK ID 368625); Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580); Tanrıöver, Cem; Yavuz, Furkan, Soler, Maria J.; Ortiz, Alberto; Covic, Adrian, and School of Medicine
- Abstract
Chronic kidney disease (CKD) will become the fifth global case of death by 2040. Its largest impact is on premature mortality but the number of persons with kidney failure requiring renal replacement therapy (RRT) is also increasing dramatically. Current RRT is suboptimal due to the shortage of kidney donors and dismal outcomes associated with both hemodialysis and peritoneal dialysis. Kidney care needs a revolution. In this review, we provide an update on emerging knowledge and technologies that will allow an earlier diagnosis of CKD, addressing the current so-called blind spot (e.g. imaging and biomarkers), and improve renal replacement therapies (wearable artificial kidneys, xenotransplantation, stem cell-derived therapies, bioengineered and bio-artificial kidneys)., Research by A.O. is supported by IS/Fondos FEDER (PI18/01 366, PI19/00 588, PI19/00 815, DTS18/00 032, ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00 064) and PERSTIGAN AC18/00 071, ISCIII-RETIC REDinREN RD016/0009), Sociedad Espanola de Nefrologia, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM, Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001) and SPACKDc PMP21/00 109, FEDER funds. RD16/0009.
- Published
- 2022
25. Visit-to-visit blood pressure variability and risk of dementia in chronic kidney disease patients: why are blood pressure changes so important in cognitive functions?
- Author
-
Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580); Yavuz, Furkan, School of Medicine, Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580); Yavuz, Furkan, and School of Medicine
- Abstract
Chronic kidney disease (CKD) is associated with cognitive functional impairment or dementia in addition to cardiovascular diseases. Aging of the population and the increasing prevalence of CKD in elderly patients are making dementia more prevalent. Blood pressure (BP) variability is an important risk factor for dementia. Although ample data link high BP variability with the risk of dementia in the general population, data on CKD patients are scarce. An observational cohort study conducted by Park et al., including 103 139 patients, demonstrated a strong association between higher visit-to-visit BP variability and increased risk of dementia in CKD patients. Both higher systolic and diastolic BP variabilities were associated with any type of dementia, including Alzheimer's and vascular dementia. Physicians must be aware of BP variability when evaluating CKD patients with hypertension., NA
- Published
- 2022
26. Future of kidney imaging: Functional magnetic resonance imaging and kidney disease progression
- Author
-
Copur, Sidar, primary, Yavuz, Furkan, additional, Sag, Alan A., additional, Tuttle, Kathherine R., additional, and Kanbay, Mehmet, additional
- Published
- 2022
- Full Text
- View/download PDF
27. Visit-to-visit blood pressure variability and risk of dementia in chronic kidney disease patients: why are blood pressure changes so important in cognitive functions?
- Author
-
Yavuz, Furkan, primary and Kanbay, Mehmet, additional
- Published
- 2022
- Full Text
- View/download PDF
28. Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM)
- Author
-
Esther M. Lafuente, Duygu Sari-Ak, Vassiliki A. Boussiotis, Yavuz-Furkan Yazicioglu, Nikolaos Patsoukis, Anthos Christofides, and Alvaro Torres-Gomez
- Subjects
Integrins ,biology ,Chemistry ,Effector ,T cell ,Integrin ,Actin remodeling ,Endothelial Cells ,Membrane Proteins ,General Medicine ,Cell biology ,Immune system ,medicine.anatomical_structure ,biology.protein ,medicine ,Cell Adhesion ,Humans ,Rap1 ,Cytoskeleton ,Antigen-presenting cell ,Adaptor Proteins, Signal Transducing - Abstract
Leukocytes, the leading players of immune system, are involved in innate and adaptive immune responses. Leukocyte adhesion to endothelial cells during transmigration or to antigen presenting cells during T cell activation, requires integrin activation through a process termed inside-out integrin signaling. In hematopoietic cells, Rap1 and its downstream effector RIAM (Rap1-interacting adaptor molecule) form a cornerstone for inside-out integrin activation. The Rap1/RIAM pathway is involved in signal integration for activation, actin remodeling and cytoskeletal reorganization in T cells, as well as in myeloid cell differentiation and function. RIAM is instrumental for phagocytosis, a process requiring particle recognition, cytoskeletal remodeling and membrane protrusion for engulfment and digestion. In the present review, we discuss the structural and molecular properties of RIAM and the recent discoveries regarding the functional role of the Rap1/RIAM module in hematopoietic cells.
- Published
- 2021
29. Deep learning in cyber security for internet of things
- Author
-
Yavuz, Furkan Yusuf, Gül, Ensar, Ünal, Devrim, and Bilgi Güvenliği Mühendisliği Ana Bilim Dalı
- Subjects
Artificial intelligence ,Cyber attack ,Cyber security ,Computer Engineering and Computer Science and Control ,Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve Kontrol - Abstract
Son zamanlarda önemi hızla artan nesnelerin internetin için siber saldırıların da önemi hızla artmaktadır. Nesnelerin internetine, ağ katmanında yapılacak saldırılar veri kay- bına ve bölünmesine yol açabilmektedir. Siber saldırılar içerisinde yönledirme saldırıları, nesnelerin internetinin yapısı ve kaynak kısıtları sebebiyle, savunmasını hayli zordur. Bu sebeple nesnelerin internetine yönelik saldırıları tespit edecek bir yönteme ihtiyaç vardır. Nesnelerin internetini izlemek ve analiz etmek, kötücül saldırıları öngörmek, beklenmeyen durumlara ayak uydurmak, önlemler almak, hassas verileri korumak ve kayıpları azalt- mak için hayati önem arz etmektedir. Biz, derin öğrenme tabanlı bir güvenlik sistemi sunuyoruz. Derin öğrenme çalışmalarının en önemli kısıtlarından biri olan veri seti ek- sikliğini gidermek için Cooja simülatörü ile ürettiğimiz ve hazırladığımız veri setini de çalışmamızın ek ürünü olarak sunuyoruz. Veri setimiz 1000'e varan düğümlü kablosuz sensör ağlarını içeriyor. Bunun yanı sıra, ölçeklendirilebilir derin öğrenme tabanlı yön- lendirme atak tespit modelleri ile nesnelerin interneti için sağlam bir güvenlik sunuyoruz. Cyber threats are a showstopper for Internet of Things (IoT) which has recently gained popularity. Network layer attacks on IoT can cause significant disruptions and loss of information. Among such attacks, routing attacks are especially hard to defend against because of the ad-hoc nature of IoT systems and resource constraints of IoT devices. Hence a an efficient approach for detecting and predicting IoT attacks is needed. For the security of IoT, detecting malicious attacks is vital to avoid of unintended consequences such as lack of availability, integrity and confidentiality. For secure IoT needs a system that is able to robust detection against routing attacks. We propose a deep-learning based for continuous security monitoring analysis for IoT. Application of deep learning for cyber-security in IoT requires the availability of substantial IoT attack data, however the lack of IoT attack data is an important issue. In our study, the Cooja IoT simulator has been utilized for generation of high-fidelity attack data, within IoT networks ranging from up to 1000 nodes. We propose a highly scalable, deep-learning based attack detection methodology for detection of IoT routing attacks with high accuracy and precision. 97
- Published
- 2018
30. The Rap1-RIAM Pathway Regulates the Expression of Integrins αEβ7(CD103) and α4β7, Which Guide T Cell Homing to Intestinal Compartments
- Author
-
Yazicioglu, Yavuz-Furkan, primary, Aksoylar, Halil-Ibrahim, additional, Pal, Rinku, additional, Patsoukis, Nikolaos, additional, and Boussiotis, Vassiliki A, additional
- Published
- 2018
- Full Text
- View/download PDF
31. The Rap1-RIAM Pathway Regulates the Expression of Integrins αEβ7(CD103) and α4β7, Which Guide T Cell Homing to Intestinal Compartments
- Author
-
Vassiliki A. Boussiotis, Yavuz-Furkan Yazicioglu, Rinku Pal, Halil-Ibrahim Aksoylar, and Nikolaos Patsoukis
- Subjects
Cell adhesion molecule ,T cell ,Immunology ,Integrin ,Cell Biology ,Hematology ,Biology ,Biochemistry ,Cell biology ,Cell membrane ,medicine.anatomical_structure ,biology.protein ,medicine ,Rap1 ,Lymphocyte function-associated antigen 1 ,Antigen-presenting cell ,Homing (hematopoietic) - Abstract
Integrin-mediated adhesion of lymphocytes to antigen presenting cells (APCs) links innate and adaptive immunity and is mandatory for the initiation of T cell immune responses. Control of lymphocyte adhesion to antigen-presenting cells (APC) is accomplished through the regulation of the principle adhesion molecule on the lymphocyte surface, lymphocyte functional antigen 1 (LFA-1), which binds to intercellular adhesion molecule 1 (ICAM-1) on the surface of APCs. Integrins also play crucial roles in cell migration to different immunological compartments such as the tumor microenvironment but also to targets of tissue and organ damage in autoimmune diseases and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. For these reasons, understanding the mechanisms implicated in LFA-1 activation and their functional implications is a subject of intense investigation. To mediate its adhesive function, LFA-1 must be activated via a process referred to as inside-out signaling, which results in conformation changes of the receptor that extends the ectodomains of the α and β chains leading to a high affinity state. Among the few signaling molecules that have been implicated in this process in hematopoietic cells are the small GTPase Rap1 and its downstream effector RIAM. RIAM is a multidomain protein that includes a talin binding region, two coiled-coiled regions, a small N-terminus proline-rich region, sequential Ras association (RA) and pleckstrin homology (PH) domains, and a large C-terminus proline-rich region, via which interacts with Ena/VASP family proteins and profilin and is recruited to the sites of actin turnover. Through its C-terminus RIAM also interacts with the SH3-domain of PLC-γ1.The RA and PH domains of RIAM function as an integral unit and as a proximity detector since both are required for translocation of RIAM to the plasma membrane. The RA domain of RIAM has specificity for Rap1-GTP whereas the PH domain binds to the PLC-γ1 substrate PI(4,5)P2. Upon interaction with Rap1-GTP, RIAM recruits talin to the LFA-1 β chain leading to its conformational change to the high-affinity state. Previously, we determined that Rap1-GTP induces expression of CD103 (integrin αE),which pairs with integrin beta 7 to form the complete heterodimer, integrin αEβ7. The chief ligand for αEβ7is E-cadherin, an adhesion molecule found on epithelial cells, important for T cell homing to intestinal sites. Moreover, expression of αEβ7(CD103) in T cells confers immunosuppressive and regulatory activity even in the absence of Foxp3. In the present study, we sought to investigate the role of Rap1-RIAM axis in the expression of integrins αEβ7(CD103) and α4β7, both responsible for T cell migration and homing to intestinal compartments, including Peyer's Patches, lamina propria and intestinal epithelium. We generated transgenic mice expressing constitutively active Rap1-GTP in T cells (Rap1-Tg) and mice with T cell-specific deletion of RIAM (RIAMf/fCD4cre). Rap1-Tg mice exhibited an increase of Teff-memory cell fractions, enhanced Treg cell differentiation and elevated expression of αEβ7(CD103), but significant reduction of total T cells in secondary lymphoid organs including Peyer's Patches, spleen and peripheric lymph nodes. These effects of Rap1-GTP were mediated by RIAM because these findings were reversed when RIAM was deleted in Rap1-Tg/RIAMf/fCD4cre mice. Consistent with a mandatory role of RIAM in these outcomes, RIAMf/fCD4cre mice displayed defective αEβ7(CD103) expression, particularly in the CD8+ T cell compartment, which inversely correlated with the expression of α4β7 resulting in > 2-fold increase of the CD8+ α4β7+ T cell fraction in secondary lymphoid organs. Rap1-Tg mice also exhibited enhanced Teff-memory, Th17 and T follicular helper (Tfh) cell differentiation in secondary lymphoid organs including Peyer's Patches, under steady-state conditions. In contrast to Treg differentiation, RIAM deletion in Rap1-Tg mice did not reduce Th17 and Tfh cells suggesting that RIAM plays a role in fate commitment processes of selective T helper cell subsets. Because αEβ7(CD103) and α4β7 guide T lymphocyte homing in the gut whereas the plasticity and reciprocal regulation of the Th17/Treg axis within gut-associated lymphoid tissues guard intestinal inflammation, our results suggest a selective role of the Rap1-RIAM pathway in gut-related immune pathologies. Disclosures No relevant conflicts of interest to declare.
- Published
- 2018
- Full Text
- View/download PDF
32. Deep Learning for Detection of Routing Attacks in the Internet of Things
- Author
-
Yavuz, Furkan Yusuf, primary, Ünal, Devrim, primary, and Gül, Ensar, primary
- Published
- 2018
- Full Text
- View/download PDF
33. Immune-class regulation in chronic Hepatitis B virus (HBV) infection and the effects of liver micro-environment on this regulation
- Author
-
Mahmut Emin Yigit, Yavuz Furkan Yazicioglu, and Sedat Gul
- Subjects
Blood transfusion ,Innate immune system ,business.industry ,medicine.medical_treatment ,biochemical phenomena, metabolism, and nutrition ,Acquired immune system ,Virology ,Virus ,Immune system ,Immunoglobulin class switching ,HBeAg ,Viral entry ,bacteria ,Medicine ,business - Abstract
The immune system contains a lot of humoral and cellular components and defends the human body. But in the case of chronic HBV infection, it becomes ineffective. HBV is a hepatotropic virus infecting 350 million people around the World chronically. HBV can be transmitted through sexual intercourse, blood transfusion and prenatally. After viral entry into the hepatocytes, the virus uncoats itself in the nuclear area and tries to escape from the immune system. This escape may occur only in the 4% of the cases which ends up with chronic HBV infection. In the first 6-8 weeks of the infection, a very weak innate immune response may be detected. In the following 12 weeks, delayed and poor adaptive immune response is mounted due to the weak innate immune response. As it’s known, the immune response against viruses is T cell-mediated. T cells defend against HBV by removing infected hepatocytes. This process changes the micro-environment of the liver determining which class of immune response should be mounted. The micro-environment and the tissue components educate dentritic cells to activate T-helper (Th) cells stimulating and recruiting proper immune cells controlling the proper immune-class. Two types of immune classes have been accounted for in this hypothesis: Th1, which is recruited in viral and bacterial infections and Th2 recruited basically in parasitic infections. The changes in the micro-environment of liver and some components of the HBV such as HBeAg may affect the immune class and even convert it from Th1 to Th2 in the case of HBV infection. The question in this hypothesis is whether the class switching (Th1 → Th2) may play role in chronicity of HBV and ineffectiveness of the adaptive immune response mounted against virus. In the light of this information, here we hypothesize that chronic HBV infection may be eradicated and prevented by keeping the liver micro-environment intact inducing Th1 immune-class and novel treatments as wells as new diagnosis methods for chronic HBV infections can be developed based on Th1 → Th2 immune class switching.
- Published
- 2016
- Full Text
- View/download PDF
34. The potential role of the circadian rhythm in immune repertoire formation and pathogenesis of immune disorders
- Author
-
Sedat Gul, Yavuz Furkan Yazicioglu, and Mahmut Emin Yigit
- Subjects
Immune system ,Hygiene hypothesis ,Antigen ,DNA repair ,Immunology ,medicine ,biology.protein ,Epigenetics ,Immune disorder ,Biology ,Antibody ,medicine.disease ,PER1 - Abstract
The incidence of immune disorders such as autoimmunity and hypersensitivity reactions has been increasing in industrialized countries recently . Although some hypotheses based on epidemiological studies have been proposed to evaluate this increase among the immune disorder cases such as “Hygiene Hypothesis”, the underlying mechanism is not clear yet. It has been well studied that impairments in immune repertoire, total diversity among the antigenic receptors such as B cell receptor, T cell receptor and antibodies, may be causative factors of several immune disorders. Although genetic aspects of these immune disorders are well established, elucidating the responsible mutations in the genes encoding the molecules having key role in the formation of immune repertoire, we still lack knowledge on what kind of environmental factors take role in the pathogenesis of these diseases. Establishment of the diversity of immune repertoire depends on the recruitment of V(D)J re-arrangement which is basically Non-Homologous End Joining (NHEJ), one of the DNA repair mechanisms, mediated pathway. Circadian rhythm which DNA repair mechanisms may have effects on V(D)J recombination through NHEJ pathway especially in the early stages of life when immune repertoire is formed. The proteins recruited in the circadian regulation of the cells and regulation of DNA repair mechanisms such as Per1, Cry1, Parp-1 ve Tim are candidate molecules which may regulate V(D)J rearrangement. We suggested in our hypothesis that a novel molecular pathways linking circadian rhythm to immune system functioning and environmental factors disrupting circadian rhythm may have potential role in the pathogenesis of several immune disorders through epigenetic control of V(D)J recombination.
- Published
- 2016
- Full Text
- View/download PDF
35. The Rap1-RIAM Pathway Regulates the Expression of Integrins aEß7(CD103) and a4ß7, Which Guide T Cell Homing to Intestinal Compartments
- Author
-
Yazicioglu, Yavuz-Furkan, Aksoylar, Halil-Ibrahim, Pal, Rinku, Patsoukis, Nikolaos, and Boussiotis, Vassiliki A
- Abstract
No relevant conflicts of interest to declare.
- Published
- 2018
- Full Text
- View/download PDF
36. Altered peptide ligands: qualitative or quantitative effects on signaling in monoclonal T cells?
- Author
-
Yazicioglu, Yavuz Furkan, Ellastad, Kristofor K., Lin, Jiaxin, and Anderson, Colin C.
- Subjects
- *
LIGANDS (Biochemistry) , *T cell receptors , *MAJOR histocompatibility complex , *CELL communication , *CELL proliferation , *EPITOPES - Abstract
Objectives: Altered peptide ligands (APLs) are derivatives of antigenic peptides containing substitutions at residues involved in T cell receptor (TCR) contact or major histocompatibility complex (MHC) binding. While these substitutions can quantitatively affect T cell signaling following APL stimulation, the question remains whether APLs can also have qualitatively different TCR signaling effects. Materials-Methods: In this study, we employed the Marilyn (CD4+ anti-H-Y) TCR transgenic system and designed several H-Y-derived APLs bearing substitutions at MHC-II anchor or TCR contact residues. Marilyn PD-1−/−T cells lacking a co-inhibitor and thus thought to be biased toward enhanced TCR signaling were also included in the assays to examine threshold effects that could mediate qualitatively different responses to APLs. The proliferative response to different concentrations of native H-Y or these APLs was examined by both in vivo and in vitro proliferation assays using mixed Marilyn and Marilyn PD-1−/−T cells. The ability of the APLs to bind MHC-II and potential for particular APLs unable to stimulate proliferation to inhibit T cell responses to native H-Y peptide were also assessed. Results: We found that Marilyn and Marilyn PD-1−/−T cells proliferated similarly in response to H-Y and all of the APLs tested in a dose dependent manner and in accordance with their predicted TCR and MHC affinity. Particular APLs could block the proliferative response of T cells to H-Y in co-culture. Conclusions: Overall our data suggest that APLs have primarily quantitatively different signaling effects on T cells, although some APLs may have utility in blocking the response to native epitopes. Our research indicated that novel further studies should be carried out to evaluate the mechanisms underlying the effects of APLs before research on APLs are translated into medicinal drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2016
37. Novel strategies in nephrology: what to expect from the future?
- Author
-
Çöpür, Sidar (ORCID 0000-0003-0190-2746 & YÖK ID 368625), Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580), Tanrıöver, Cem, Yavuz, Furkan, Soler, Maria J., Ortiz, Alberto, Covic, Adrian, and School of Medicine
- Subjects
Artificial kidney ,Bioengineering ,Chronic kidney disease ,Induced Pluripotent stem cells ,Xenotransplantation ,Urology and nephrology - Abstract
Chronic kidney disease (CKD) will become the fifth global case of death by 2040. Its largest impact is on premature mortality but the number of persons with kidney failure requiring renal replacement therapy (RRT) is also increasing dramatically. Current RRT is suboptimal due to the shortage of kidney donors and dismal outcomes associated with both hemodialysis and peritoneal dialysis. Kidney care needs a revolution. In this review, we provide an update on emerging knowledge and technologies that will allow an earlier diagnosis of CKD, addressing the current so-called blind spot (e.g. imaging and biomarkers), and improve renal replacement therapies (wearable artificial kidneys, xenotransplantation, stem cell-derived therapies, bioengineered and bio-artificial kidneys)., Research by A.O. is supported by IS/Fondos FEDER (PI18/01 366, PI19/00 588, PI19/00 815, DTS18/00 032, ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00 064) and PERSTIGAN AC18/00 071, ISCIII-RETIC REDinREN RD016/0009), Sociedad Espanola de Nefrologia, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM, Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001) and SPACKDc PMP21/00 109, FEDER funds. RD16/0009.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.